Inspire Medical Systems (INSP) interim CFO discloses equity holdings on Form 3

Rhea-AI Filing Summary

Inspire Medical Systems' interim CFO Richard Buchholz filed an initial Form 3 reporting his beneficial ownership in Inspire Medical Systems, Inc. He directly holds 44,567 common shares, including 5,974 restricted stock units, and has employee stock options over 4,376, 5,450, 5,924 and 17,300 shares. He also reports indirect ownership of 1,475 common shares held by his son.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Buchholz Richard

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/09/2026

3. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	44,567(1)	D
Common Stock	1,475	I	By Son
Common Stock	1,475	I	By Son

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(2)	02/09/2034	Common Stock	4,376	$194.87	D
Employee Stock Option (Right to Buy)	(3)	02/10/2033	Common Stock	5,450	$263.16	D
Employee Stock Option (Right to Buy)	(4)	02/11/2032	Common Stock	5,924	$227.53	D
Employee Stock Option (Right to Buy)	(4)	12/14/2030	Common Stock	17,300	$194.82	D

Explanation of Responses:

1. Includes 5,974 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs will vest in accordance with the terms of the underlying awards.

2. The option vested and became exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

3. The option vested and became exercisable as to 25% of the underlying shares on February 10, 2024. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

4. The option is fully vested and exercisable.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney.

	/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Inspire Medical Systems (INSP) interim CFO report on this Form 3?

The interim CFO, Richard Buchholz, reports his initial beneficial ownership in Inspire Medical Systems common stock, including directly held shares, restricted stock units, stock options, and indirect holdings attributed through his son, as of the Form 3 event date of January 9, 2026.

How many Inspire Medical Systems (INSP) common shares does Richard Buchholz directly own?

Richard Buchholz directly owns 44,567 shares of Inspire Medical Systems common stock. This figure includes 5,974 restricted stock units, each representing a contingent right to receive one share upon vesting under the terms of the applicable equity award agreements.

What indirect Inspire Medical Systems (INSP) holdings are reported on behalf of Richard Buchholz?

The Form 3 reports 1,475 shares of Inspire Medical Systems common stock as indirectly owned by Richard Buchholz through his son. These indirect holdings are shown separately from his direct holdings, indicating beneficial ownership through a related family member.

What stock options in Inspire Medical Systems (INSP) does the interim CFO hold?

Richard Buchholz holds several employee stock options to buy Inspire Medical Systems common stock: options over 4,376, 5,450, 5,924 and 17,300 shares, each with specified exercise prices and expiration dates between February 2032 and February 2034, as shown in the Form 3 table.

How do the restricted stock units (RSUs) for INSP reported by the interim CFO vest?

The filing states that 5,974 restricted stock units each represent a contingent right to receive one share of Inspire Medical Systems common stock. These RSUs will vest according to the terms of the underlying awards, which govern timing and conditions for share delivery.

What are the vesting terms for key Inspire Medical Systems (INSP) stock options held by the interim CFO?

One option vested 25% on February 9, 2025, and another 25% on February 10, 2024. For each, the remaining 75% vests in 36 equal monthly installments, contingent on Richard Buchholz’s continuous employment with Inspire Medical Systems through the respective vesting dates.